Company Performance Metrics
- Zilin Zhang: Co-Founder
- Saisri Akondi: CEO and Co-Founder
At D.Sole, we are advancing the development of remote patient monitoring in podiatry with our multimodal foot insoles designed for the early detection and monitoring of diabetic foot complications, such as ulcers and deformities. Our complete foot physiological data along with advanced machine learning algorithms provides clinicians with
evidence-based insights for targeted foot treatments. We are ten times more affordable than current market options and detect 15-foot complications—far outperforming competitors who detect just one. D.Sole could save wound clinics in hospitals over $100 million annually by lowering readmission rates for foot complications. Private insurers could save over $1 billion by cutting costs on amputations and wound care.
